The Evolving Outsourcing Landscape in Pharma R&D: Pros and Cons of Different Models

The execution of drug discovery and development in pharma has changed dramatically in the last 20 years. Pharmaceutical companies no longer rely solely on large groups of internal scientists to generate ideas and execute the science, but have turned to contract research organizations (CROs) for their research and development needs. Join Bart DeCorte of MercachemSyncom for an overview of the drivers behind this radical transformation. During this free interactive broadcast discover the various outsourcing and partnering models and criteria for CRO selection as well as how the partner selection and outsourcing model can be the difference between success and failure. An overview of the evolving role of CROs in drug discovery in the past 20 years A profile of different outsourcing models that can be considered What to look for as you select a CRO to partner with